Last reviewed: July 13, 2026
Last updated: July 13, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide pens contain enough medication for multiple weekly injections, but the exact duration varies based on your personalized starting dose and treatment protocol. Many patients wonder how long their medication supply will last and when to schedule their next refill. PlexusDx delivers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with dosing adjusted to your individual metabolic needs—your dose may need to go up, but your price won't.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding Tirzepatide Pen Capacity and Injection Frequency
Tirzepatide pens are designed for once-weekly subcutaneous injections, meaning you use one pen every seven days. Each pen contains a set amount of medication, typically enough for one or two weeks depending on the concentration and total volume prepared by your compounding pharmacy. Your starting dose determines how quickly you progress through a pen—lower initial doses preserve more supply than higher maintenance doses.
Weekly injection timing creates a predictable refill schedule. If your pen contains two weeks' worth of medication at your current dose, you'll need a fresh supply every 14 days. PlexusDx patients receive monthly supplies aligned with their treatment plan, ensuring continuous access without gaps in therapy. This monthly structure simplifies refill management and prevents the stress of running out unexpectedly.
How Dose Escalation Affects Your Pen Supply Duration
Most tirzepatide treatment protocols start with a low dose and increase gradually over weeks or months to reach a therapeutic level. This means your first pen may last longer than your second or third, since you're using less medication per injection initially. A typical escalation pattern might increase your dose every one to two weeks until reaching your target maintenance dose.
Once you stabilize at a maintenance dose, your pen consumption becomes predictable and consistent. Your body's response to tirzepatide—measured by hunger reduction, appetite control, and weight loss—determines whether your dose stays the same or increases further. PlexusDx aligns your refill schedule with your dose trajectory, so you always have the right supply when your current pen empties. The flat monthly pricing structure means dose changes never affect your cost.
Tracking Your Tirzepatide Supply and Planning Refills
Keeping track of your injection dates prevents accidental supply shortages and missed doses. Mark your injection day on a calendar or set a phone reminder for each Thursday (or whichever day you choose). Count backward from your refill date to identify when to request your next month's supply—typically 7 to 10 days before your current pen empties.
PlexusDx makes refill timing simple by delivering monthly supplies consistent with once-weekly injection schedules. If you receive your shipment on the first of each month, you'll use approximately four pens over 28 days at a maintenance dose. Some months may require slightly more or less depending on dose adjustments, but your flat monthly rate covers all dosing variations. Customer support can help you coordinate refills if your schedule shifts or you're between dose levels.
Compounded Tirzepatide vs. Brand Medications: Supply Differences
Brand-name tirzepatide (Mounjaro) comes in fixed-dose pre-filled pens, limiting customization of your dose progression. Compounded tirzepatide from licensed 503A pharmacies, like those used by PlexusDx, can be prepared at any concentration your doctor prescribes, allowing smoother dose escalation and personalized supply planning. This flexibility means your pen duration aligns exactly with your medical needs rather than rigid commercial packaging.
Compounded medications cost significantly less because they bypass brand markup while maintaining the same active pharmaceutical ingredient. PlexusDx delivers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan—no insurance required, HSA/FSA eligible—making consistent supply affordable long-term. You control when to escalate your dose without worrying that higher doses will increase your monthly expense.
Optimizing Your Tirzepatide Therapy With Genetic Personalization
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Patients with favorable GLP1R variants may reach therapeutic benefit at lower doses and require fewer pen refills overall. Others might benefit from faster dose progression to activate multiple metabolic pathways simultaneously. PlexusDx maps 14 peptide pathways and 150+ genetic insights to create a personalized roadmap for your weight loss journey. Understanding your genetic profile transforms pen duration from a mystery into a predictable, optimized part of your treatment plan.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many weeks does one tirzepatide pen typically last?
At a stable maintenance dose, one tirzepatide pen usually lasts one to two weeks depending on the concentration and volume your compounding pharmacy prepares. During dose escalation phases, a single pen may last longer since you're injecting smaller amounts weekly. PlexusDx delivers monthly supplies that account for your dose progression, so you receive the right quantity every month.
Does tirzepatide dose escalation change how long my supply lasts?
Yes. During the typical 8–12 week escalation phase, each pen lasts progressively shorter as your weekly dose increases toward maintenance. Once you reach your target dose, pen consumption becomes consistent. Your doctor adjusts refill timing based on your current dose level, and PlexusDx ensures you never run out by coordinating monthly deliveries with your treatment stage.
Why is compounded tirzepatide more affordable than Mounjaro brand pens?
Compounded tirzepatide from licensed 503A pharmacies contains the identical active medication as brand Mounjaro but eliminates corporate markup and packaging costs. PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan flat—meaning your dose can increase without your price increasing—while brand pens typically cost $900–$1,300 monthly, even with insurance. No membership fee, HSA/FSA eligible, and available in all 50 states.
What if I need to increase my tirzepatide dose—will my refill schedule change?
Yes, your refill frequency may adjust slightly when you escalate doses, but your monthly cost remains $249 per month with PlexusDx (no flat per-compound pricing tiers). Your doctor will coordinate the timing of your dose increase with your pharmacy to avoid gaps. Customer support helps synchronize your refill dates with your escalation schedule so you transition smoothly to higher doses.
How does the PlexusDx Precision Peptide Genetic Test help with tirzepatide dosing?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Okay to Skip a Week of Mounjaro?
How Much Weight Loss Can You Expect on 5mg Mounjaro?